|
|
TARGETING RAB6-KM23-1-MEDIATED COMPARTMENTALIZED TRAFFICKING AS A NOVEL THERAPEUTIC APPROACH TO ALZHEIMERS DISEASE |
| 5R21AG057218-02 |
MULDER, KATHLEEN M |
NIA |
2019 |
|
|
PHAGE DISPLAY DETECTION OF ALZHEIMER'S DISEASE MARKERS |
| 5R21AG058013-02 |
RUOSLAHTI, ERKKI |
NIA |
2019 |
|
|
APATHY IN ALZHEIMER'S DISEASE: INVESTIGATION OF THE INTERACTION BETWEEN PROLINE AND COMT FOR TREATMENT TARGETING TO POSITIVELY IMPACT QUALITY OF LIFE |
| 5R21AG058020-02 |
CLELLAND, CATHERINE L |
NIA |
2019 |
|
|
CONNECTIVITY AND GENETIC ASSOCIATIONS IN PARKINSON'S DISEASE |
| 5R21AG058118-02 |
HERSKOVITS, EDWARD H |
NIA |
2019 |
|
|
DEVELOPING NOVEL TREATMENTS FOR PARKINSON'S DISEASE BY TARGETING MOLECULAR PATHWAYS THAT HAVE BEEN SHOWN TO MODULATE AGING |
| 5R21AG058241-02 |
MOORE, DARREN JOHN |
NIA |
2019 |
|
|
AGING IN AUTISM SPECTRUM DISORDER: OUTCOMES AND INDICATORS |
| 5R21AG059051-02 |
LODI-SMITH, JENNIFER |
NIA |
2019 |
|
|
IDENTIFICATION OF PLASMA HYDROXYSPHINGOLIPIDS AS BIOMARKERS OF DEMYELINATION AND NEURODEGENERATION UNDERLYING PHYSICAL FUNCTION DECLINE IN OLDER ADULTS |
| 5R21AG059068-02 |
LI, DANNI |
NIA |
2019 |
|
|
INVESTIGATING THE ROLE AND MECHANISM OF RIPK1 IN MEDIATING CEREBROVASCULAR PATHOLOGY OF AD |
| 5R21AG059073-02 |
YUAN, JUNYING |
NIA |
2019 |
|
|
SENSATION AND PSYCHIATRY: LINKING AGE-RELATED HEARING LOSS TOLATE-LIFE DEPRESSION AND COGNITIVE DECLINE |
| 5R21AG059130-02 |
RUTHERFORD, BRET R |
NIA |
2019 |
|
|
BRAIN CIRCUIT MECHANISMS IN SLEEP STAGE SPECIFIC PROCESSING OF MEMORY |
| 5R21AG059179-02 |
VARGA, ANDREW W |
NIA |
2019 |
